✦ LIBER ✦

Incidence of neuropathy in 395 patients with ovarian cancer treated with or without cisplatin

✍ Scribed by R. Gerritsen Van Der Hoop; M. E. L. Van Der Burg; W. W. Bokkel Ten Huinink; J. C. Van Houwelingen; J. P. Neijt

Publisher: John Wiley and Sons
Year: 1990
Tongue: English
Weight: 610 KB
Volume: 66
Category: Article
ISSN: 0008-543X
DOI: 10.1002/1097-0142(19901015)66:8<1697::aid-cncr2820660808>3.0.co;2-g

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

β-glucuronidase activity in adrenals of

β-glucuronidase activity in adrenals of patients with or without cancer

✍ Cornelia Hoch-Ligeti; Henry H. Grantham JR.; Joan M. Arvin 📂 Article 📅 1969 🏛 John Wiley and Sons 🌐 English ⚖ 622 KB

K-ras mutation in sputum of patients wit

K-ras mutation in sputum of patients with or without lung cancer

✍ Ze'ev Ronai; Marina S. Yabubovskaya; Edith Zhang; Gennady A. Belitsky 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 493 KB 👁 2 views

K-ras mutation appears in about 60% of patients with non-small-cell lung cancer (NSCLC). This freqLency and its presence in normal appearing tissues point to the potential of ras oncogene mutation to serve as a good biomarker. Using enriched PCR (EPCR), which enables the detection of one mutant alle

Incidence of cancer in postmyocardial in

Incidence of cancer in postmyocardial infarction patients treated with short-acting nifedipine and diltiazem

✍ Ken Kanamasa; Akio Kimura; Masaru Miyataka; Toshihiko Takenaka; Kinji Ishikawa; 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 83 KB 👁 1 views

Recent reports suggest a possible link between nifedipine (but not diltiazem) and an increased risk of cancer in patients being treated with calcium antagonists. ## METHODS. A total of 1054 postmyocardial infarction patients were divided randomly into those being treated with calcium antagonists

Race does not impact outcome for advance

Race does not impact outcome for advanced ovarian cancer patients treated with cisplatin/paclitaxel : An Analysis of Gynecologic Oncology Group Trials

✍ John H. Farley; Chunqiao Tian; G. Scott Rose; Carol L. Brown; Michael Birrer; G. 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 199 KB

Clinical implications of learned food av

Clinical implications of learned food aversions in patients with cancer treated with chemotherapy or radiation therapy

✍ Richard D. Mattes; Walter J. Curran Jr.; Jane Alavi; William Powlis; Richard Whi 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 822 KB

Background. The nutritional implications of learned food aversions were evaluated in patients with newly diagnosed cancer receiving either chemotherapy (n = 53) or radiation therapy (n = 49). Methods. Aversion incidence was determined by questionnaires and a food challenge. Measures of dietary and

A randomized trial of cyclophosphamide a

A randomized trial of cyclophosphamide and doxorubicin with or without cisplatin in advanced ovarian carcinoma. A gynecologic oncology group study

✍ George Omura; John A. Blessing; Clarence E. Ehrlich; Alexander Miller; Edgardo Y 📂 Article 📅 1986 🏛 John Wiley and Sons 🌐 English ⚖ 593 KB